NCT06644898 The Effect of Gait Training Using Different Slope Types on Balance in COPD Patients
| NCT ID | NCT06644898 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Acibadem University |
| Condition | Pulmonary Disease, Chronic Obstructive |
| Study Type | INTERVENTIONAL |
| Enrollment | 51 participants |
| Start Date | 2025-04-09 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 51 participants in total. It began in 2025-04-09 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Although COPD is basically a respiratory system disease, its effects are not limited to the respiratory system. In this context, one parameter affected in COPD patients is balance. Recent studies have highlighted the importance of assessing balance and incorporating it into treatment options such as pulmonary rehabilitation. In this context, we aim to diversify the training by using different slope types (downhill, level, uphill) in aerobic exercise training, which is a strong component of pulmonary rehabilitation, and to evaluate the effect of slope type on balance. Testing different types of inclines in aerobic exercise training has the potential to result in different muscular gains. We anticipate that this may result in different balance gains.
Eligibility Criteria
Inclusion Criteria: * Being diagnosed with COPD (A, B, E groups according to GOLD assessment) * Ambulate on your own * Not having any contraindications for exercise Exclusion Criteria: * Being in GOLD 4 stage in spirometric evaluation * Presence of hypoxemia * Participation in another pulmonary rehabilitation program within the last 6 months * Having an exacerbation in the last 1 month * Being diagnosed with additional respiratory disease (asthma, bronchiectasis, etc.) * Having had pulmonary surgery * Having an orthopedic, neurological or cardiac disease that affects exercise * Having uncontrolled hypertension or diabetes * Presence of malignancy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06644898 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying Pulmonary Disease, Chronic Obstructive. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06644898 currently recruiting?
Yes, NCT06644898 is actively recruiting participants. Contact the research team at meryem.bektas@acibadem.edu.tr for enrollment information.
Where is the NCT06644898 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06644898 clinical trial?
NCT06644898 is sponsored by Acibadem University. The trial plans to enroll 51 participants.